Today The ROS1ders published a white paper titled, “Sustaining and Accelerating Research for ROS1 Cancer.” The document summarizes key themes and subsequent discussions from two ROS1ders Research Roundtable virtual meetings, which brought together members of The ROS1ders with leading ROS1 clinicians and researchers. The report also offers a “Call to Action” to help move ROS1 cancer research forward.
The ROS1ders, Inc. is a non-profit public benefit corporation with an international membership of patients and family members dealing with ROS1+ cancer across cancer types. Members use their professional skills and passion to help other ROS1+ patients and families and accelerate research.
Janet Freeman-Daily, co-founder and Board Chair
The ROS1ders, Inc.
Donate to our research